BSE to discontinue trading in Ranbaxy from April 6
The BSE has decided to delist Ranbaxy scrip from S&P BSE 100, S&P BSE 200, S&P BSE 500, S&P BSE Healthcare and S&P BSE Carbonex indices from April 6.
Mar 27, 2015, 21:19 PM IST
Ranbaxy Q3 net loss widens to Rs 1,029.72 cr
The company had posted a net loss of Rs 158.94 crore during the October-December period of previous fiscal.
Jan 28, 2015, 15:47 PM IST